Advertisement

Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes

  • Masahiro TakadaEmail author
  • Masakazu Toi
Invited Review Article
  • 61 Downloads

Abstract

Recently, a number of new minimally invasive image-guided percutaneous ablation treatments, including cryoablation, radiofrequency ablation, microwave ablation, high-intensity focused ultrasound, laser ablation, and irreversible electroporation have been developed. Several studies have shown the feasibility and safety of these cryoablation therapies for the treatment of benign breast tumors and small invasive breast cancer. Although the complete response rate of cryoablation for breast cancer is reported to be relatively good, most studies enrolled a small number of patients, and so reliable conclusions could not be drawn. In this review, we introduce the mechanisms of action of cryoablation, and summarize the current literature on the efficacy and safety of cryoablation for breast cancer. Cryoablation also induces an immunomodulatory effect, which is an interesting topic of research in the era of immune checkpoint inhibitors. Cryoablation for primary tumor may enhance the treatment effect of immune checkpoint inhibitors in patients with breast cancer. Further investigations of this new therapeutic strategy are needed.

Keywords

Breast neoplasm Ablation techniques Cryosurgery Immunotherapy 

Notes

Compliance with ethical standards

Conflict of interest

M. Takada has received honoraria from Chugai, AstraZeneca, Kyowa Hakko Kirin, and Eisai; and has received a research Grant from Eisai. M. Toi has no conflict of interest to disclose.

References

  1. 1.
    Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108.  https://doi.org/10.3322/caac.21262 CrossRefGoogle Scholar
  2. 2.
    Fisher B, Jeong JH, Anderson S et al (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. New Engl J Med 347:567–575.  https://doi.org/10.1056/NEJMoa020128 CrossRefGoogle Scholar
  3. 3.
    Fleming MM, Holbrook AI, Newell MS (2017) Update on image-guided percutaneous ablation of breast cancer. AJR Am J Roentgenol 208:267–274.  https://doi.org/10.2214/AJR.16.17129 CrossRefGoogle Scholar
  4. 4.
    Chu KF, Dupuy DE (2014) Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 14:199–208.  https://doi.org/10.1038/nrc3672 CrossRefGoogle Scholar
  5. 5.
    Yang WL, Addona T, Nair DG et al (2003) Apoptosis induced by cryo-injury in human colorectal cancer cells is associated with mitochondrial dysfunction. Int J Cancer 103:360–369.  https://doi.org/10.1002/ijc.10822 CrossRefGoogle Scholar
  6. 6.
    Alblin RJ, Soanes WA, Gonder MJ (1971) Prospects for cryo-immunotherapy in cases of metastasizing carcinoma of the prostate. Cryobiology 8:271–279CrossRefGoogle Scholar
  7. 7.
    Abdo J, Cornell DL, Mittal SK et al (2018) Immunotherapy plus cryotherapy: Potential augmented abscopal effect for advanced cancers. Front Oncol 8:85.  https://doi.org/10.3389/fonc.2018.00085 CrossRefGoogle Scholar
  8. 8.
    Kumar AV, Patterson SG, Plaza MJ (2019) Abscopal effect following cryoablation of breast cancer. J Vasc Interv Radiol 30:466–469.  https://doi.org/10.1016/j.jvir.2018.12.004 CrossRefGoogle Scholar
  9. 9.
    Sabel MS, Kaufman CS, Whitworth P et al (2004) Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial. Ann Surg Oncol 11:542–549.  https://doi.org/10.1245/ASO.2004.08.003 CrossRefGoogle Scholar
  10. 10.
    Simmons RM, Ballman KV, Cox C, ACOSOG Investigators et al (2016) A phase II trial exploring the success of cryoablation therapy in the treatment of invasive breast carcinoma: Results from ACOSOG (Alliance) Z1072. Ann Surg Oncol 23:2438–2445.  https://doi.org/10.1245/s10434-016-5275-3 CrossRefGoogle Scholar
  11. 11.
    Mauri G, Sconfienza LM, Pescatori LC et al (2017) Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: A systematic review and meta-analysis. Eur Radiol 27:3199–3210.  https://doi.org/10.1007/s00330-016-4668-9 CrossRefGoogle Scholar
  12. 12.
    Machida Y, Shimauchi A, Igarashi T, et al (2018) MRI findings after cryoablation of primary breast cancer without surgical resection. Acad Radiol.  https://doi.org/10.1016/j.acra.2018.07.012(Epub ahead of print)Google Scholar
  13. 13.
    Pusceddu C, Melis L, Ballicu N et al (2017) Cryoablation of primary breast cancer in patients with metastatic disease: considerations arising from a single-centre data analysis. Biomed Res Int 2017:3839012.  https://doi.org/10.1155/2017/3839012 CrossRefGoogle Scholar
  14. 14.
    Beji H, Pilleul F, Picard R et al (2018) Percutaneous cryoablation of breast tumours in patients with stable metastatic breast cancer: safety, feasibility and efficacy. Br J Radiol 91:20170500.  https://doi.org/10.1259/bjr.20170500 CrossRefGoogle Scholar
  15. 15.
    Sabel MS, Nehs MA, Su G et al (2005) Immunologic response to cryoablation of breast cancer. Breast Cancer Res Treat 90:97–104.  https://doi.org/10.1007/s10549-004-3289-1 CrossRefGoogle Scholar
  16. 16.
    Liang S, Niu L, Xu K et al (2017) Tumor cryoablation in combination with natural killer cells therapy and herceptin in patients with HER2-overexpressing recurrent breast cancer. Mol Immunol 92:45–53.  https://doi.org/10.1016/j.molimm.2017.10.003 CrossRefGoogle Scholar
  17. 17.
    McArthur HL, Diab A, Page DB et al (2016) A pilot study of preoperative single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer with comprehensive immune profiling. Clin Cancer Res 22:5729–5737.  https://doi.org/10.1158/1078-0432.CCR-16-0190 CrossRefGoogle Scholar
  18. 18.
    Page DB, Yuan J, Redmond D et al (2016) Deep sequencing of T-cell receptor DNA as a biomarker of clonally expanded TILs in breast cancer after immunotherapy. Cancer Immunol Res 4:835–844.  https://doi.org/10.1158/2326-6066.CIR-16-0013 CrossRefGoogle Scholar
  19. 19.
    Adams S, Loi S, Toppmeyer D, et al (2018) Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: Cohort B of the Phase 2 KEYNOTE-086 study. Ann Oncol.  https://doi.org/10.1093/annonc/mdy518 (Epub ahead of print)Google Scholar
  20. 20.
    Adams S, Schmid P, Rugo HS, et al (2018) Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the Phase 2 KEYNOTE-086 Study. Ann Oncol.  https://doi.org/10.1093/annonc/mdy517 (Epub ahead of print)Google Scholar
  21. 21.
    Heery CR, O'Sullivan-Coyne G, Madan RA et al (2017) Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial. Lancet Oncol 18:587–598.  https://doi.org/10.1016/S1470-2045(17)30239-5 CrossRefGoogle Scholar
  22. 22.
    Nanda R, Chow LQ, Dees EC et al (2016) Pembrolizumab in patients with advanced triple-negative breast cancer: Phase Ib KEYNOTE-012 Study. J Clin Oncol 34:2460–2467.  https://doi.org/10.1200/JCO.2015.64.8931 CrossRefGoogle Scholar
  23. 23.
    Rugo HS, Delord JP, Im SA et al (2018) Safety and antitumor activity of pembrolizumab in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer. Clin Cancer Res 24:2804–2811.  https://doi.org/10.1158/1078-0432.CCR-17-3452 CrossRefGoogle Scholar
  24. 24.
    Schmid P, Adams S, Rugo HS, IMpassion130 Trial Investigators et al (2018) Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer. New Engl J Med 379:2108–2121.  https://doi.org/10.1056/NEJMoa1809615 CrossRefGoogle Scholar
  25. 25.
    Morin J, Traore A, Dionne G et al (2004) Magnetic resonance-guided percutaneous cryosurgery of breast carcinoma: technique and early clinical results. Can J Surg 47(5):347–351Google Scholar
  26. 26.
    Pfleiderer SO, Marx C, Camara O et al (2005) Ultrasound-guided, percutaneous cryotherapy of small (%3c or = 15 mm) breast cancers. Invest Radiol 40(7):472–477CrossRefGoogle Scholar
  27. 27.
    Pusztaszeri M, Vlastos G, Kinkel K et al (2007) Histopathological study of breast cancer and normal breast tissue after magnetic resonance-guided cryotherapy ablation. Cryobiology 55(1):44–51.  https://doi.org/10.1016/j.cryobiol.2007.05.002 CrossRefGoogle Scholar
  28. 28.
    Littrup PJ, Jallad B, Chandiwala-Mody P et al (2009) Cryotherapy for breast cancer: a feasibility study without excision. J Vasc Interv Radiol 20(10):1329–1341.  https://doi.org/10.1016/j.jvir.2009.06.029 CrossRefGoogle Scholar
  29. 29.
    Manenti G, Scarano AL, Pistolese CA, et al. (2013) Subclinical breast cancer: minimally invasive approaches. Our experience with percutaneous radiofrequency ablation vs. cryotherapy. Breast Care (Basel) 8(5):356–360. doi:10.1159/000355707Google Scholar
  30. 30.
    Pusceddu C, Sotgia B, Amucano G et al (2014) Breast cryoablation in patients with bone metastatic breast cancer. J Vasc Interv Radiol 25(8):1225–1232.  https://doi.org/10.1016/j.jvir.2014.05.001 CrossRefGoogle Scholar
  31. 31.
    Gajda MR, Mireskandari M, Baltzer PA, et al. (2014) Breast pathology after cryotherapy. Histological regression of breast cancer after cryotherapy. Pol J Pathol 65(1):20–28CrossRefGoogle Scholar
  32. 32.
    Cazzato RL, de Lara CT, Buy X et al (2015) Single-centre experience with percutaneous cryoablation of breast cancer in 23 consecutive non-surgical patients. Cardiovasc Intervent Radiol 38(5):1237–1243.  https://doi.org/10.1007/s00270-015-1181-5 CrossRefGoogle Scholar
  33. 33.
    Poplack SP, Levine GM, Henry L et al (2015) A pilot study of ultrasound-guided cryoablation of invasive ductal carcinomas up to 15 mm with MRI follow-up and subsequent surgical resection. AJR Am J Roentgenol 204(5):1100–1108.  https://doi.org/10.2214/AJR.13.12325 CrossRefGoogle Scholar

Copyright information

© Japan Society of Clinical Oncology 2019

Authors and Affiliations

  1. 1.Department of Breast SurgeryKyoto University HospitalKyotoJapan

Personalised recommendations